Detalles de la búsqueda
1.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 436, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589856
2.
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 563, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711003
3.
Mind the gap with Europe. Why public interest cannot be a good reason to perform observational and epidemiological research?
Tumori
; 110(1): 6-9, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548055
4.
Observational studies - The Cinderella of the Italian research system.
Tumori
; 109(6): 524-528, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37029687
5.
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials.
Eur J Cancer
; 190: 112945, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441940
6.
Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials.
Eur J Cancer
; 189: 112910, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301718
7.
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial.
J Clin Oncol
; 40(14): 1562-1573, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35258987
8.
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer.
Eur J Cancer
; 144: 31-40, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33321462
9.
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer.
Clin Cancer Res
; 27(9): 2505-2514, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547199
10.
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study.
Cancers (Basel)
; 13(11)2021 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34200267
11.
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.
Clin Colorectal Cancer
; 19(3): 156-164, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32513593
12.
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer.
Clin Cancer Res
; 26(5): 1017-1024, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31740551
13.
Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy.
J Clin Oncol
; 37(33): 3099-3110, 2019 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31539295
Resultados
1 -
13
de 13
1
Próxima >
>>